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Signal Transduction by G Proteins in Cardiac Tissues John W. Fleming, PhD; Patricia L. Wisler, PhD; and August M. Watanabe, MD M ammalian cell systems communicate with one another and respond to the physio-V logical demands of the organism through messages transmitted via the nervous and circulatory systems. Molecular "signals" (ligands) sent by one group of cells via the nervous or circulatory system are "received" by specialized macromolecules (receptors) on another group of responding cells. After the signal ligand interacts with its receptor, the message must be transferred to intracellular metabolic machinery (effectors) of the responding cell ( Figure 1 ). With the discovery of cyclic AMP (cAMP) in 1957 and the enzyme responsible for its synthesis [adenylate cyclase, ATP pyrophosphate-lyase (cyclizing) E.C.4.6.1.1] by Earl Sutherland and Theodore Rall, the second-messenger hypothesis of hormone action was born. Early reports from Sutherland's laboratory demonstrated that ligands such as epinephrine and carbachol could interact with plasma membranes to either stimulate or inhibit, respectively, the generation of cAMP.1 cAMP, in turn, modulates intracellular effectors, resulting in the characteristic physiological response to a given signal. These discoveries ushered in a large series of investigations describing the effects of many ligands on the activity of adenylate cyclase in various tissues from diverse organisms. However, the simple concept of a single molecular entity fulfilling the receptor, transducer, and effector roles quickly gave way to a model with multiple separate molecular entities responsible for these functions (Figure 1 ). Receptors and adenylate cyclase (effector) were resolved as unique protein macromolecules. 23 Even before this accomplishment, Rodbell et a14 demonstrated the absolute requirement for GTP in glucagon action, and this suggested that an additional component was necessary for the transduction of the ligand signal to the intracellular effector. Based on its functional dependence on GTP, the transducer that Rodbell et a14 inferred has been variously designated in the literature as G (GTP binding), N (nucleotide binding), or G/F (GTP/fluoride) protein. Thus, efforts of the past decade have focused on the purification of the individual components of the hormone-sensitive adenylate cyclase system (i.e., receptor, transducer, and effector) and the mechanisms of interaction of these proteins.
Much progress has been made; ,B-adrenergic receptors,5-9 muscarinic cholinergic receptors, 10 13 adenylate cyclase, 14-18 and multiple G proteins19,20 have been purified, cloned, and functionally characterized to varying degrees. As the details of molecular structure and function have been revealed for the adenylate cyclase system, it has been realized that G proteins do not represent an isolated signaling system. Rather, the G proteins represent a family of signal transducers whose most basic characteristics have been highly conserved throughout evolution. For example, similar signaling proteins are also present in bacteria (Saccharomyces)21 and cellular slime molds (Dictyostelium). 22 Furthermore, functionally related GTP-binding proteins are involved in additional cellular functions23 as diverse as vision,24 protein synthesis,25 microtubule assembly,26 olfaction,27 and oncogene function28 ( Table 1) . Some of these appear to be members of a subset of low-molecularweight (-20 kDa) G proteins involved in activities different from transduction of external signals across the cell membrane. Only cardiac transmembrane signal-transducing G proteins are considered here.
Extracellular chemical signal transduction in cardiac cells is now known to occur predominantly through f31and /32-adrenergic and muscarinic cholinergic receptors as cardiac function is regulated by the sympathetic and parasympathetic branches of the autonomic nervous system. a,-Adrenergic receptors also mediate signal transduction in cardiac cells, but their contribution appears to be more important in pathological conditions. Adenosine A1-receptors are also coupled to adenylate cyclase via G proteins. [29] [30] [31] All of these sarcolemmal receptors are coupled to sarcolemmal G proteins, which, in turn, interact with various intracellular effector proteins to produce the cellular physiological response. G protein-regulated macromolecules known to affect cardiac cellular responses include the enzymes adenylate cyclase, which 2nd Messenger f Enzymes, Ion Channels Cellular Response FIGURE 1. Schematic of signal transduction in cells. A ligand, a signal molecule or hormone, interacts with a receptor molecule, which is often embedded in the cell membrane. The ligand-receptor interaction activates a transducer molecule (exemplified by the G proteins), which, in turn, modulates an effector protein, often an enzyme. The eJfector may then produce second-messenger biochemicals that regulate enzymes and ion channels involved in evoking the specialized cellular response. Altematively, the transducer molecule may directly influence ion channels, bypassing the interposition of a second messenger in the interaction. produces the second-messenger cAMP, and phospholipase C, which produces second-messengers inositol trisphosphate (IP3) and diacylglycerol (DAG).32 There is speculative evidence that phospholipase A2, which liberates arachidonic acid from phospholipids,33 and guanylate cyclase, which generates the second-messenger cyclic GMP (cGMP), may also be regulated by G proteins in cardiac tissue.34
G Protein Common Structure and Regulatory Cycle
At least three types of G protein have been identified in cardiovascular tissue.20 G, protein mediates stimulation of adenylate cyclase and production of the second-messenger cAMP via both I31-and f32-adrenergic receptors. G, also mediates 3-adrenergic modulation of voltage-dependent ion channels. 35 Gi protein mediates inhibition of 83-adrenergic-stimulated adenylate cyclase activity by muscarinic cholinergic, a1-adrenergic, and adenosine Al-receptor agonists. [29] [30] [31] Gi also directly couples muscarinic receptors to atrial and pacemaker cell K' channel activation. Go is present in cardiovascular tissue, but its role is unclear. There is ample evidence that Go regulates Ca21 channels in brain where Go is very abundant. Gq is a recently identified 42-kDa pro-tein36 that may prove to be the toxin-insensitive G protein involved in muscarinic and a1-adrenergic receptor stimulation of phospholipase C37 and phospholipase A2. 33 Each of the G proteins, regardless of its functional designation as GQ, Gi, Go. or Gq, is a heterotrimer consisting of a-, ,B-, and y-subunits (Ga, G,3, and G,).
Ga-subunits contain the binding site for guanine nucleotides and a specific GTP hydrolytic enzyme (GTPase), the activity of which is increased in the presence of the G,3Y complex. Ga interacts reversibly with its respective receptor and effector molecules, and confers specificity to the holoprotein by virtue of a-subunit structural heterogeneity relative to the more homogeneous structures of /8-and y-subunits. Another characteristic of Ga-subunits is that most of them possess one or two sites for nicotinamide adenine dinucleotide (NAD)-dependent ADP-ribosylation. This covalent modification of a-subunits is catalyzed by bacterial toxins -by cholera toxin in the case of GQa and by pertussis toxin in Gia, Goa. Gqa appears not to be ADP-ribosylated by either toxin. ADP-ribosylation of Gsa inhibits its GTPase activity, thus irreversibly activating the subunit to stimulate Neither Phospholipase A2 (+) a1-adrenergic ADP-ribosylation, capacity of the Ga-subunit to be ADP-ribosylated in a reaction catalyzed by the listed bacterial toxin; mChR, muscarinic cholinergic receptor; CT, cholera toxin; PT, pertussis toxin. £-@3A/-GDP QATP cAMP FIGURE 2. Schematic of the transduction of hormonal signals to regulation of adenylate cyclase (AC) and other proteins in myocardial cells. The central roles of G proteins and the availability of G;,-subunits in the regulatory processes are emphasized. R, and Ri, stimulatory and inhibitory receptors; *, activated moieties. adenylate cyclase and ion channels. ADP-ribosylation of Gia and Go, inhibits the interaction between the subunits and receptors. These functional modifications make ADP-ribosylation a means for detecting, quantifying, and localizing G proteins.
GQand G,-subunits are the most homogenous proteins of all of the G proteins. They form tightly cohesive complexes that interact with Ga-subunits.
The G proteins undergo a regulatory cycle consisting of binding of GTP to the Ga-subunit of the GaQ,, heterotrimeric complex, dissociation of the inhibitory Gq complex, and interaction of Ga, GTP with the effector (Figure 2 ). Termination of the cycle occurs with the hydrolysis of GTP to GDP and reassociation of Ga GDP with Q6. to form the inactive complex.
Receptor-agonist complexes and guanine nucleotides bind with negative cooperativity to GQ,,19; thus, activated receptors (e.g., agonist-bound 83-adrenergic receptors) catalyze the exchange of GTP for GDP ( Figure 2 ). Signal transduction occurs when activated receptor-agonist complex interacts with Gapy, GDP in the presence of GTP, thus favoring the activated state of the G protein and interaction with the effector. These features of the GTP regulatory cycle are essentially similar, to the degree known, for all of the signal-transducing G proteins. Regulation of receptor affinity is a consequence of the negatively cooperative interaction of agonistreceptor complexes and GTP at the G proteins. [38] [39] [40] Receptor affinity for agonist is relatively high when the agonist-receptor complex is associated with a G protein complexed with GDP. Upon binding of the ago-nist-receptor complex to the G protein, GDP is released, freeing the nucleotide site on the a-subunit for interaction with GTP. Binding of GTP to the G protein results in the dissociation of the agonistreceptor complex. Because the rate of dissociation of the agonist-receptor complex from G is faster than the rate of G protein inactivation (GTPase activity), each agonist-receptor complex catalytically activates multiple G proteins (signal amplification). 41 When not complexed to a G protein, receptors have low affinity for agonist; thus, observation of a GTP-mediated decrease in agonist affinity for receptors is a common characteristic of receptors coupled to G proteins. Figure 2 ). Gia is distinguished by the ability of pertussis toxin to transfer an ADP-ribose moiety from NAD to the a-subunit of the G protein. 47 [32P]ADP-ribosylation of Gia allowed its identification and functional modification; once this technique was available, purifica-tion48 quickly followed using modifications of the techniques used to purify G,. Gi, has been purified from several sources,19 and similar but unique complementary DNA clones have been obtained. Cloning studies have demonstrated several distinct Gia-subunits in the range of 40-41 kDa. Gia has been shown to inhibit adenylate cyclase49,50 and directly couple cell membrane receptors to ion channels.51 Go (G "other") was first observed as a 39-kDa pertussis toxin substrate in addition to Gi in brain,52,53 and Go,, has now been cloned.54 Go is very similar to Gi, binds GTP, and has been shown by Florio and Sternweis55 to regulate muscarinic receptor affinity for agonists in brain. Although relatively few specific functions have been directly demonstrated for GO, many possibilities exist.
Gqa is a newly purified G protein subunit that is refractory to ADP-ribosylation by cholera toxin or pertussis toxin.36,56 It migrates on polyacrylamide gel electrophoresis as a 42-kDa protein and has been identified in a number of mammalian tissues, including brain and lung (greatest concentrations) and heart. Isolated Gqa exhibits slow rates of GDP-GTP exchange and GTP hydrolysis in comparison to other Ga-subunits. The Gqa protein may be considered a CHOLERA TOXIN -41 KDa candidate for the pertussis toxin-insensitive protein that couples muscarinic and a,-adrenergic receptors to phosphoinositide hydrolysis. Gza is also a recently purified and cloned G protein subunit that is not ADP-ribosylated by either bacterial toxin. It is a 40-kDa protein that is found in greatest concentration in brain but has not been identified in cardiac tissue. 57 Originally isolated and considered a complex of /3and y-subunits, G,,y was apparently structurally and functionally identical regardless of its source of isolation. 19 However, refined purification and molecular biological techniques have indicated unique properties of different G,., species and revealed possible important physiological roles for these subunits. 58 Although some structural and antigenic heterogeneity has been noted among fl-subunits, the similar functional activities of G,,7-subunits from diverse sources dictate consideration of G, exchange between different G-subunits in the process of signal transduction. The concept of functional interchangeability of P-subunits with each other and with different a-subunits is strengthened by their lack of tissuespecific distribution. In rat, fly-subunit concentration was highest in brain and lung and lowest in heart and skeletal muscle.58 Heterogeneity exists to some degree between GY-subunits, allowing the possibility of unique populations of Gfly that may be specific for distinct receptors.59,60
It has been suggested that the fly-subunits of the G proteins constitute a hydrophobic "anchor" by which the a-subunits are associated with the plasma membrane.6' This model suggests that the a-subunit could be released into the cytoplasm upon GTP-catalyzed activation and dissociation of a G protein.61,62 It has been further suggested that the released a-subunit might be covalently modified by any number of known covalent modifications,62 resulting in presently unknown regulatory functions. However, recent experiments suggest that myristoylation of Gi, Goa, Gqa, but not Gsa provides for continued association of the a-subunit with cell membrane after fly has dissociated as a result of G protein activation.63,64 In addition, N-myristoylation of Ge,, facilitated its association with the fly complex to form the heterotrimer G0. 65 Thus, Gs complexes function to inhibit interaction of Ga-subunits with effector proteins by complexing with the GQ,s and probably facilitate binding of G i: were identified: Mr, 41 ,000 (Gi,r); Mr. 45 KDa0t 39,000 (G,,). A single substrate for cholera toxin was identified: Mr, 45,000 (G,e). Reprinted with permission. 72 proteins to cell membranes.42 It has been suggested that GP,-subunits themselves mediate ion channel activation through stimulation of phospholipase A2, although the physiological significance of this action in heart is unclear.33,66
Measurement of G Proteins
Methods for indirectly measuring G proteins include observation of the lowering of receptor-agonist binding affinities in the presence of guanine nucleotides and a reconstitution assay that uses cell membranes from cultured cells genetically deficient in G, (S49 cyc-cells). In addition, the dependence of a biochemical reaction (e.g., adenylate cyclase activation) upon guanine nucleotides is an indirect measure of G protein function.
Bacterial toxins have proven to be invaluable probes for the direct study of G protein stoichiometry and function. Using [32P]NAD as substrate, cholera toxin catalyzes the [32P]ADP-ribosylation of the a-subunit of GS and pertussis toxin (islet activating protein) catalyzes the [j2P]ADP-ribosylation of the a-subunit of Gi and Go. ADP-ribosylation of G, decreases its affinity for Gf4344 and inhibits its GTPase activity, resulting in persistent activation of adenylate cyclase activity by GTP.67 ADP-ribosylation of Gie increases its affinity for Gfl., inhibits its GTPase activity, and abolishes its ability to mediate inhibition of adenylate cyclase activity.38'68-72 We have used cholera and pertussis toxins to identify the G proteins mediating muscarinic stimulation of GTPase activity and inhibition of adenylate cyclase activity ( Figure 3 ).71,72 Toxin-catalyzed ADP-ribosylation of Ga-subunits measures only a fraction of the total concentration of G proteins in the cell, but the toxin-labeled fraction appears to correspond to functional G protein. 73 Antibodies raised against G protein subunit-specific peptides interact with corresponding epitopes on G proteins and in this way provide a direct measure of the specific G protein subunit. When concentration of G protein is assessed by antibodies, tissue content of G protein appears to be greater than that measured by ADP-ribosylation. These discrepant values for tissue G protein density may indicate that some of the G protein is inaccessible for ADPribosylation because ADP-ribosylation sites are sequestered from the bacterial toxin, NAD, or both, -.... %%..::..,...::::
::-::...:
:::-::..:....:.. .:.:::::.:::..,:.,. G Proteins in Cardiac Regulation G proteins are centrally involved in regulation of cardiac function because they couple receptors to adenylate cyclase and phospholipid hydrolysis systems and ion channels.
Sympathetic, parasympathetic, and hormonal controls of cardiac function depend on various types of receptors in the cell membrane to translate signals to particular cellular responses.7677 Both 81and 2adrenergic receptors in cardiac tissue are distributed throughout the mammalian heart ( Figure 4 ). In general, in the atrial myocardium of normal hearts, /31-receptors account for 60-70% of the total 13-receptor population, whereas in ventricular myocardium, 131 -receptors comprise 70-80% of all ,3-receptors. 78 Stimulation of both I31and 812-receptors by catecholamines generates activated G, to stimulate production of cAMP (via adenylate cyclase). Cyclic AMP, in turn, activates protein kinase A (PKA), which phosphorylates various proteins in the myocyte. Some of the protein-PKA interactions and the associated cellular responses include 1) phosphorylation and activation of phosphorylase kinase for mobilization of glycogen stores79; 2) phosphorylation of troponin I, which decreases Ca2' affinity of the protein80; 3) phosphorylation of myofibrillar C pro-tein81; 4) phosphorylation and activation of inhibitor-1 of type 1 phosphatase82; 5) phosphorylation of phospholamban, which regulates the activity of Ca2+-ATPase in sarcoplasmic reticulum membranes83; 6) phosphorylation of a 15-kDa sarcolemmal protein, the function of which is unknown84; 7) phosphorylation of voltage-sensitive Ca21 channels for increased Ca21 influx across the sarcolemma85; and 8) phosphorylation of sarcolemmal Na+ channels to effectively close them when membranes are depolarized.86
Alternatively, the hormone receptor-activated G, may directly gate Ca21 channels85 and Na+ channels86 in the heart, without interposition of cAMP.
a1-Adrenergic receptors are the predominant, if not the only, a-subtype in mammalian myocardium ( Figure   5 ). Under normal physiological conditions, cardiac aladrenergic receptor stimulation may not have important physiological effects; however, a1-receptors probably function as a backup inotropic system for conditions in which the f3-adrenergic response is compromised.
Stimulation of a1-receptors by catecholamines in several tissues activates a pertussis toxinand cholera toxin-insensitive G protein (perhaps Gqj) to stimulate phospholipase C, which catalyzes hydrolysis of membrane phosphoinositides.87,88 The resulting second messengers 1P3 and diacylglycerol (DAG) may release Ca2+ from intracellular stores and stimulate protein kinase C, respectively. The increase in cytoplasmic Ca2+ concentration may produce increased inotropy. Catecholamine stimulation of myocyte a1-adrenergic receptors is also coupled to other effector proteins by a pertussis toxin-sensitive G protein (Gi); these effectors include a background K' current and inhibition of ,3-adrenergicstimulated adenylate cyclase.8990
Muscarinic cholinergic receptors mediate parasympathetic control of heart function ( Figure 6 ). The primary effects of muscarinic stimulation are opposite those of f3-adrenergic stimulation (i.e., stimulation of muscarinic receptors leads to decreases in heart rate and force of contraction). Acetylcholine binds to muscarinic receptors that activate pertussis tor may be coupled to Gq, which, in the presence of GTP, dissociates its Gq a-subunit to stimulate phospholipase C (PLC). This results in the formation of second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), which increase intracellular Ca21 levels-IP3 by releasing Ca2+ from intracellular stores and DAG by stimulating protein kinase C (PKC) to phosphorylate sarcolemmal Ca21 channels. PKC may also catalyze the phosphorylation of the aj-receptor to inactivate it. The a2-adrenergic receptor is coupled to Gi, which, in the presence of GTP, dissociates its Gi a-and f3y-subunits to inhibit adenylate cyclase (AC) and the consequent protein kinase A (PK4) phosphorylation of cellular proteins. G, a-subunit also couples a2-receptors directly to atrial K' channels for their stimulation. The a2-receptor is coupled via Gia to stimulation. The a2-receptor is coupled via Gia to stimulation of PLC. In addition, the a2-receptor may directly activate a Na+-H+ exchange mechanism. Data compiled with permission. 135, 136 fects that usually result from stimulation of muscarinic receptors. Muscarinic stimulation via this pathway leads to generation of 1P3 and DAG. The physiological significance of the muscarinic-phosphoinositide connection is not yet clear.20 Muscarinic receptor activation of a pertussis toxin-sensitive (G1) G protein also directly stimulates atrial K' channels, which are inwardly rectifying.35 In addition, muscarinic receptor stimulation increases production of cGMP, but the role of cGMP in regulating cardiac function is not yet defined.10,91
Muscarinic inhibition of cardiac adenylate cyclase activity was first observed during initial characterization of the enzyme nearly 25 years ago when Murad and coworkers1 in Sutherland's laboratory reported that carbachol inhibited the enzyme in crude cardiac membrane preparations. During the past decade, it has become appreciated that receptor-coupled stimulation and inhibition of adenylate cyclase activity are mediated by G, and Gi, respectively.38 As discussed previously, G, and Gi undergo similar GTP regulatory cycles; however, the mechanism by which muscarinic receptor interaction with Gi attenuates adenylate cyclase activity has been controversial.
Inhibition of adenylate cyclase activity has been proposed to occur by at least two mechanisms: directly by Gia. GTP inhibition of adenylate cyclase and/or indirectly via inactivation of Gs, GTP by G,y released from Gi and possibly GQ.38 As discussed above, activation of Ga with GTP results in the dissociation of inhibitory GQ,B which is very similar in inhibitory function for each of the G proteins. Although the a-subunit of Gi has been shown to inhibit adenylate cyclase activity,49,50 it does so weakly.42 Such inhibition by Gia apparently was not regulated by muscarinic receptors in heart.83 An interesting new model for hormone inhibition of adenylate cyclase has been developed by Hildebrandt and Kohnken.92 They propose that G1, is the primary mediator of hormone inhibition when G, is activated by a hormone, whereas G,37 functions as a mediator of inhibition of adenylate cyclase basal activity. Thus, Birnbaumer93 believes that G protein-mediated inhibition of adenylate cyclase must be considered in light of these two independent mechanisms, at least until further studies resolve the issue of which is more relevant physiologically. We reported that the adenylate cyclase system of canine cardiac sarcolemma is subject to dual regulation by muscarinic and ,B-adrenergic receptor agonists. 94 In that study, the muscarinic agonist methacholine was shown to attenuate activation of adenylate cyclase by GTP. However, basal adenylate cyclase activity and activation of the enzyme by the nonhydrolyzable analogue of GTP, Gpp(NH)p, was unaffected by methacholine. This study and others suggested involvement of a GTP hydrolytic activity (GTPase) in the mechanism by which muscarinic agonists inhibit GTP-activated adenylate cyclase. 70, 72, 95 We identified a high-affinity GTPase activity in canine cardiac sarcolemma that was related to adenylate cyclase activity.70'72 This GTPase activity was stimulated by muscarinic agonists, and pretreatment of the membranes with pertussis toxin attenuated the ability of muscarinic agonists to both stimulate GTP hydrolysis and inhibit adenylate cyclase activity. 72 In separate experiments, we treated whole dogs with pertussis toxin and subsequently purified sarcolemmal membranes from control and treated animals for assessment of muscarinic regulation of GTPase and adenylate cyclase activities.71 In vivo administration of pertussis toxin 2 days before animal death and membrane purification resulted in an animal model in which Giand GO-mediated biochemical mechanisms could be studied. The sarcolemma from the toxin-treated animals displayed characteristics of an adenylate cyclase system in which inhibitory regulatory pathways had been attenuated: Vagal modulation of heart rate was completely lost, and muscarinic stimulation of GTPase activity (Figure 7 ) and inhibition of adenylate cyclase activity (Figure 8 ) by oxotremorine were attenuated.7' In addition, the ability of guanine nucleotides to regulate muscarinic receptor affinity for agonist was abolished.7'
As mentioned earlier, pertussis toxin catalyzes the ['2P]ADP-ribosylation of the a-subunits of both Gi and G., and these have been identified in canine cardiac sarcolemma (Figure 3 adenylate cyclase directly in cyc-membranes isolated from variant murine S49 lymphoma strains lacking Gs, inhibition by this mechanism is relatively small1738,70 and requires the presence of the nonphysiological plant diterpene forskolin. 70 Therefore, interactions that regulate the availability of Ge3, in the membrane may be the more significant in cardiac sarcolemma, and this implies that G released from G. may also be an important component of muscarinic inhibition of adenylate cyclase activity (Figure 2) . Due to the possible exchange of subunits in the plasma membrane, any interaction that impinges on the interaction of one G protein component could influence the function of the others, including stimulation and inhibition of adenylate cyclase activity. In this regard, another protein has been described that may modulate G protein interactions. In several systems including cardiac sarcolemma, an additional protein has been described that is required for the cholera toxin-catalyzed ADP-ribosylation of GS. 72, 96, 97 This protein is often called ADP-ribosylation factor (ARF) and has been identified in plasma membranes and cellular cytosol. Interest in this protein has increased recently due to several factors. First, one species of ARF has been purified to homogeneity96,97 and identified as a GTP-binding protein. 97 Second, endogenous ADP-ribosyltransferases have been identified and purified.98'99 Third, recent evidence further supports a possible physiological role for endogenous ADP-ribosylation of G, that is modulated by Gi and endogenous adenosine.74'100 Although the role of ARF in any physiological process is undefined, there is speculation that ARF may play a role in the ADP-ribosylation of G, by endogenous ADP-ribosyltransferases, thus influencing receptor regulation of adenylate cyclase activity by the G proteins.
In association with muscarinic attenuation of ,-adrenergic agonist-induced increases in cAMP generation, attenuation of a variety of subsequent enzymatic reactions has also been demonstrated.101 Thus, inhibition by acetylcholine of /8-adrenergic agonist-induced phosphorylase activation and glycogenolysis has been noted. Phosphorylation of phospholamban is also attenuated, but this occurs to a greater extent than concomitant attenuation of cAMP production. 34 Thus, the possibility exists that muscarinic cholinergic agonists may antagonize ,B-adrenergic agonists effects through additional mechanisms (e.g., through activation of phosphatases).
G Protein Regulation of Ion Channels
,B-Adrenergic receptors and muscarinic cholinergic receptors in the myocardium are known to control ion conductances across the cell membrane.102 Each receptor type uses G proteins in the transduction of the signals received. In studies of both kinds of receptors, there is evidence that a G protein can couple its receptor to the adenylate cyclase-protein kinase system for indirect regulation of ion channels and that G proteins can also couple a receptor -directly to an ion channel, thus acting as a direct gating mechanism.
For indirect control of ion current, ,B-adrenergic agonists activate GQ, which stimulates cAMP production and promotes phosphorylation of voltage-sensitive Ca2' channels for increased influx of Ca2' across the sarcolemma. 85 In the same manner, ,e3-adrenergic agonists cause phosphorylation of sarcolemmal Na+ channels to close them when membranes are depolarized. 86 For more direct control of cardiac membrane currents, ,B-adrenergic receptors appear to be directly linked to activation of Ca2' and K' channels, and to inactivation of Nat and Mg`+ channels by G, proteins.35 Recent investigations with cardiac myocytes revealed biphasic f-adrenergic stimulation of Ca2' current. 85 There was a direct (non-cAMP dependent), fast (10 msec) response to isoproterenol mediated by G,. Diffusion was assumed to be ratelimiting in this reaction. The second phase was an indirect (cAMP dependent), slow (5-10 seconds) response, also mediated by Gs. The accumulation of cAMP appeared to be the rate-limiting step. This fast-slow biphasic modulation of Ca'+ current by /3-adrenergic stimulation may explain reflex stimulation of heart rate. The fast phase, where Gs protein directly links the receptor and the ion channel, has kinetics that fit the response time (1.5 seconds) of reflex sympathetic modulation of heart rate. The slow phase may maintain longer-term 8-adrenergic stimulation of heart rate. Also in cardiac myocytes, G, protein was implicated in the direct inhibition of Nat currents. 35 The effect was more pronounced when the membranes were depolarized.
Muscarinic receptors use Gi (or Gi-like protein) to mediate their cAMP-associated indirect regulation of cardiac ion conductances. The slow inward current carried predominantly by Ca', Isi, is decreased by acetylcholine primarily in association with decreases in intracellular cAMP. This effect of muscarinic receptor stimulation is probably coupled via Gi to inhibition of adenylate cyclase.103 A positive inotropic effect of acetylcholine occurs in pertussis toxintreated and embryonic chick hearts at concentrations of .10 gM. In this concentration range, activation of phosphoinositide hydrolysis has been reported. This response is not prevented by adrenergic blockade, nor does cAMP increase. The response is blocked by atropine, suggesting that it is muscarinic receptor mediated. There is also evidence of an increase in Ca21 influx.103 Recent experiments now indicate that cAMP levels can be increased by muscarinic receptor stimulation but that this increase is secondary to muscarinic stimulation of phosphoinositol hydrolysis to form IP3, which releases intracellular Ca 2 to stimulate Ca2t-calmodulin-dependent adenylate cyclase.12 Recent data implicate decreased Ca21 conductance in frog heart with decreased levels of cAMP, which resulted from increased activity of a cGMP-dependent phosphodiesterase. Generation of the cGMP was clearly associated with muscarinic agonist action.51
Muscarinic receptors also use Gi to mediate non-cAMP-associated direct regulation of ion channels. One component of the attenuation of cardiac function by muscarinic receptor agonists such as acetylcholine results from hyperpolarization of atrial cells via effects on K' permeability and specific K' current (ik. Ach).'104105 Because pertussis toxin blocks K' channel activation by acetylcholine,106 G proteins have been implicated in muscarinic regulation of these channels. As discussed previously, pertussis toxincatalyzed modification of Gia results in increased affinity of Gi for Gir. Thus, both the a and Bly species of the G protein are rendered inactive by toxin action, and assignment of the role of individual subunits would be risky based on observation of toxin experiments alone. Based on prior assumptions that the a-subunit is the primary modulator of the effector, it might be assumed that a Gi-like protein is responsible for modulation of atrial Kt channels. Working with this assumption, Yatani et al107 demonstrated elegantly that a purified pertussis toxin substrate from human erythrocytes activated K+ channels in guinea pig atria in a manner similar to that of acetylcholine and GTP. The same laboratory, using purified human erythrocyte G protein subunits, found that Gia, but not Gi, activated K+ channels in guinea pig atrial membrane patches.108 However, acid and its metabolites, such as leukotrienes and prostaglandins.33,66," 10 Muscarinic regulation of atria and ventricles is different. For example, muscarinic agonists have powerful direct negative chronotropic effects on atrial myocardium and sinoatrial and atrioventricular nodal tissues. Muscarinic agonists have direct negative inotropic effects on atrial myocardium. Acetylcholine increases ik in atria but not in ventricles."' Muscarinic agonists have minimal direct negative inotropic effects on ventricular myocardium, but they indirectly modify ventricular myocardial contractility by attenuating the effects of agents that increase cAMP levels. With the recent advances in G protein biochemistry, investigations have begun to focus on whether fundamental differences in G protein identity, structure, stoichiometry, or function can explain these differences in muscarinic regulation of atrial and ventricular myocardia. Martin et al"2 demonstrated that muscarinic receptor affinity for agonists is the same in atrial and ventricular membranes, and that regulation of receptor affinity by guanine nucleotides was the same in membranes from the two regions. Using pertussis toxin-catalyzed ["P]ADPribosylation to quantitate Gia and G0. in myocardial membranes from 8-day-old chick embryos, these investigators found these G proteins to have similar densities and identical peptide maps. Thus, Gia and Goa appear to be similar in atria and ventricles. It is possible, therefore, that a unique G protein is coupled to atrial muscarinic receptors and accounts for certain tissue-specific regulatory mechanisms. Final interpretation of these studies will be most interesting and should contribute significantly to our understanding of regional differential autonomic regulation of the heart.
G Proteins in Cardiac Development and the Role of Innervation
There is growing ontological evidence that the acquisition of myocardial regulation by muscarinic receptors parallels the biochemical development of G proteins in cardiac membranes. Two examples have been studied in some detail, embryonic chick and rat hearts. The embryonic chick heart acquires functional parasympathetic innervation on days 10-12 of embryonic life. 13 Kirby and Aronstam114 demonstrated that an increased density of muscarinic receptors coincides with the appearance of myocardial responsiveness to parasympathetic stimulation of these hearts. The purification of G proteins and the development of biochemical and immunologic probes for these proteins allowed the assessment of G protein subunit stoichiometry in developing tissues. Using quantitative immunoblot assays, Luetje et al"l5 demonstrated quantitative changes in G protein subunits that correlate with alterations in the functional regulation of adenylate cyclase activity. For example, adenylate cyclase activity was initially more sensitive to inhibition by carbachol in atrial tissue than in ventricular tissue. Increased atrial sensitivity to muscarinic inhibition coincided with a 44% greater level of Gi than of G. or G, in that tissue. In addition, the ability of GTP to inhibit basal adenylate cyclase activity paralleled alterations in G protein components. The loss of GTP inhibition of basal adenylate cyclase activity, which occurred during atrial development, coincided with an 80% increase in the level of Gp between days 13 and 15 in the atrial tissue.
That changes in G protein stoichiometry occurred at approximately the same time as the tissue acquired functional parasympathetic innervation suggests that innervation may play an important role in the regulation of G protein stoichiometry as well as the density of the muscarinic receptors with which the transducing proteins interact. 116 Regulation of G protein subunits by innervation during development has been further supported by changes that occur in myocardial regulation as the rat develops from neonate into adult. In these experiments, it was observed that the beating response of ventricular myocytes to a,-adrenergic agents changes from positive chronotropic to negative chronotropic with maturation. However, coculture of the neonatal myocytes with sympathetic neurons resulted in a reversal of the a,-adrenergic response pattern to phenylephrine from positive chronotropic to negative chronotropic. Furthermore, appearance of the negative chronotropic response to phenylephrine coincided with the acquisition of a 41-kDa, Gi-like protein. Pertussis toxin-catalyzed ADP-ribosylation of the 41-kDa protein resulted in reversal of the effects of maturation. The negative chronotropic response to a-adrenergic stimulation was converted to the immature positive chronotropic response. The a,-induced negative chronotropy in adult hearts is mediated by a pertussis toxin-sensitive G protein and by Na,K-ATPase activation, whereas the neonatal positive chronotropy is mediated by a pertussis toxin-insensitive G protein and an unknown effector.90 Thus, during development, there appears to be a regulatory influence of nerves on the stoichiometry and/or function of G proteins and receptors, and further discoveries in this area will probably be important to clinical cardiology.
Role of G Proteins in Cardiovascular
Disease States In view of the known effects of certain disease states on hormone receptors, it is reasonable to hypothesize that some diseases may also be associated with alterations in one or more of the G proteins. Indeed, in both animal models and humans, evidence has been adduced to suggest a role for altered G proteins in pathophysiological conditions. Most of the correlation of G protein status to cardiovascular function arises from work with experimental animal models. After laying the groundwork in animal studies, researchers have begun to move toward assaying G protein levels in available human cardiovascular tissues.
Among the animal models of chronic heart failure, pigs with volume overload cardiac hypertrophy showed evidence of decreased Gsa in cardiac cell membranes as well as decreased 13-adrenergic receptor density and reduced sensitivity to the chronotropic effects of isoproterenol.118 Dogs with pressure overload cardiac hypertrophy also demonstrated decreased GQa as measured by ADP-ribosylation and decreased ability of the membrane preparation to reconstitute a G protein-coupled receptor-adenylate cyclase system in S49 cyc-membranes.1"9 In the case of myocardial ischemia induced by 1 hour of occlusion in conscious dogs, Gs levels and function were decreased, and ,B-adrenergic receptor levels were increased. This finding suggests that reduced G, protein may underlie the uncoupling of ,3-adrenergic receptors from adenylate cyclase.120 In mice afflicted Steinberg et al,1"7 whose experiments focused on with Chagas' disease. an infection with the protozoan Trypanosoma cruzi, ADP-ribosylation assays indicated that G,, as well as Gi, concentrations were reduced in cardiac cell membranes. These findings explain the reduced ability of adenylate cyclase to respond to stimulatory and inhibitory agents.12' The femoral arteries of spontaneously hypertensive rats display reduced relaxation response to /3-adrenergic agonists as well as to dopamine and histamine. The defect has been traced to an apparent functional loss of G, protein. 122 In the autosomal recessively inherited cardiac failure model, the cardiomyopathic Syrian hamster, there is also a loss of Gs, function but not a quantitative loss of Gsa protein or its messenger RNA (mRNA) when measured by immunological and recombinant DNA techniques. Thus, the loss or modification of a protein required for posttranslational modification of GS for its functional integrity may be the mechanism in this model.123
In addition to an apparent loss of functional Gsa,, cardiomyopathic Syrian hamster heart tissue gave evidence of increased Gia protein in that a,-adrenergic receptor stimulation resulted in a greater-thannormal contractile response that could be eliminated by pertussis toxin treatment.124 Increased Gia content was also immunologically measured in hearts of experimentally hypothyroid rats. In addition, the concentration of ,3-subunit of G proteins was found to be increased. There was no effect of hypothyroidism on Gsa quantities in rat hearts. More detailed studies revealed that the mRNAs for the G protein subunits ai2, aB3, P1, and 12 were all increased in hearts of hypothyroid rats. Despite these increases related to the Gi protein, adenylate cyclase activity in these same membranes was greater than normal, and there was no indication of enhanced sensitivity to agents that inhibit adenylate cyclase through the Gi protein. '25 There also is the possibility that changes in G protein subunits affect one effector system (e.g., ion channels) in preference to another (e.g., adenylate cyclase). In general, in cardiovascular tissue, no significant alterations in quantity or function of G proteins have been detected in the hyperthyroid state. This is in contrast to findings that hyperthyroidism lowered Gia and Goa in rat adipose tissue. 126 In failing human hearts, cell membranes, when assayed by ADP-ribosylation, demonstrate increased levels of pertussis toxin-sensitive G protein (Gia and GO,) and unchanged levels of cholera toxin-sensitive G protein (G,,). Along with these differences from normal, failing human hearts had decreased numbers of ,B-adrenergic receptors and decreased basal and 13-agonist-stimulated adenylate cyclase activity. '27 Further investigation of failing human hearts revealed increased content of Gia128 and Gi mRNA, specifically, the mRNA that encodes at,, the a,subunit thought to be involved in muscarinic opening of atrial K' channels.129 Evidence for reduced levels of Gs protein in failing human hearts is much less strong. In biopsy samples of ventricular tissue, agents that stimulate adenylate cyclase via G, were less efficacious in pathological heart tissue than in normal tissue. 130 In idiopathic dilated cardiomyopathy, a small decrease in GS was measured immunologically, but the decrease did not match the much larger decreases in functional measures of G,.131 Mononuclear leukocytes in patients with congestive heart failure have a decreased population of 8-adrenergic receptors compared with normal hearts. These leukocytes also demonstrate reduced levels of Gsa, as assayed by ADP-ribosylation.'32 There is some concern about the validity of using quantitation values of receptors and G proteins derived from peripheral blood cells as reflections of those same parameters in cardiac tissue.79
Summary
The role of G proteins in mediating the responses of the heart to circulating catecholamines and to the influences of the autonomic nervous system is of special interest to cardiologists. It is evident that G proteins are essential links in the cascade of biochemical events that ensue when neurotransmitters and hormones interact with receptors on myocardial cells.
It is unlikely that dysfunction of G proteins plays a role in cardiovascular pathophysiology. With current methologies, especially molecular biological and recombinant DNA techniques, and with transgenic animal models that can relate physiological function and specific gene dosage,133 some cardiovascular diseases may be traced to G protein-related defects.
